Skip to main content
SpringerLink
Log in

Calculation of Administered Doses of Iodine-131 in the Treatment of Thyroid Disease

  • Chapter
Pediatric Nuclear Medicine/PET

  • 1162 Accesses

Abstract

In some instances patients present with thyroid cancer that does not seem to fit the usual treatment guidelines as set forth in conventional texts. For example, there may be an unusual distribution of thyroid remnants or metastases or there sometimes are extensive metastases to the lung or other organs. In these cases knowledge about regional uptake of therapeutic iodine-131 (131I) is useful.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 209.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Benua RS, Cicale NR, Sonenberg M, et al. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. AJRRadium Ther Nucl Med 1962;87:171–82.

    CAS  Google Scholar 

  2. Thomas SR, Maxon HR, Kereiakes JG, et al. Quantitative external counting techniques enabling improved diagnostic and therapeutic decisions in patients with well-differentiated thyroid cancer. Radiology 1977;122(3):731–7.

    PubMed  CAS  Google Scholar 

  3. Maxon HR 3rd, Englaro EE, Thomas SR, et al. Radioiodine-131 therapy for well-differentiated thyroid cancer—a quantitative radiation dosimetric approach: outcome and validation in 85 patients. J Nucl Med 1992;33(6):1132–6.

    PubMed  Google Scholar 

  4. Maxon HR, Thomas SR, Hertzberg VS, et al. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med 1983;309(16):937–41.

    Article  PubMed  CAS  Google Scholar 

  5. Harbert JC, Rocha AFG. Textbook of Nuclear Medicine, 2nd ed. Philadelphia: Lea & Febiger, 1984.

    Google Scholar 

  6. Stabin MG. The OLINDA/EXM personal computer code. http://www.doseinfo-radar.com/ OLINDA.html.

    Google Scholar 

  7. Erwin W, Groch MW. NucliDose—quantitative radionuclide imaging and MIRD dosimetry. http://www.nuclear.uhrad.com/nuclidos.htm.

    Google Scholar 

Download references

Authors
  1. Robert E. Zimmerman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Nuclear Medicine, Children’s Hospital, Boston

    S. T. Treves MD (Chief, Professor of Radiology) (Chief, Professor of Radiology)

  2. Harvard Medical School, Boston, MA, 02115, USA

    S. T. Treves MD (Chief, Professor of Radiology) (Chief, Professor of Radiology)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Zimmerman, R.E. (2007). Calculation of Administered Doses of Iodine-131 in the Treatment of Thyroid Disease. In: Treves, S.T. (eds) Pediatric Nuclear Medicine/PET. Springer, New York, NY. https://doi.org/10.1007/978-0-387-32322-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-32322-0_4

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-32321-3

  • Online ISBN: 978-0-387-32322-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation